Stanford University
This presentation is the property of its rightful owner.
Sponsored Links
1 / 36

George Segall, M.D. PowerPoint PPT Presentation


  • 69 Views
  • Uploaded on
  • Presentation posted in: General

Stanford University. PET Myocardial Perfusion Imaging: Protocols and Procedures. George Segall, M.D. PET Perfusion Agents. Diffusible tracers. RadioisotopeFormHalf-life MeV. Rubidium-82 ( 82 Rb)Chloride75 sec3.15 Nitrogen-13 ( 13 N)Ammonia10 min1.19

Download Presentation

George Segall, M.D.

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


No slide title 1264205

Stanford University

PET Myocardial Perfusion Imaging: Protocols and Procedures

George Segall, M.D.


No slide title 1264205

PET Perfusion Agents

Diffusible tracers

RadioisotopeFormHalf-life MeV

Rubidium-82 (82Rb)Chloride75 sec3.15

Nitrogen-13 (13N)Ammonia10 min1.19

O-15 (15O)Water 110 sec1.72

Copper-62 (62Cu)PTSM 9.8 min2.94

Potassium-38 (38K)Chloride 7.6 min2.70

Carbon-11 (11C)Butanol20 min0.96

PTSM, pyruvaldehyde methylthiosemicarbazone


No slide title 1264205

Medicare Coverage Policy

1995Rb-82 PET for myocardial perfusion

1998F-18 deoxyglucose PET and SPECT for myocardial viability

2003N-13 ammonia for myocardial perfusion


No slide title 1264205

Medicare Coverage Policy for

Rb-82 and N-13 ammonia

PET whether at rest alone, or rest with stress, is approved when PET is

• performed in place of SPECT, or

• used following SPECT when results are equivocal, technically uninterpretable, or discordant with clinical care

SPECT may not be used following an inconclusive PET


No slide title 1264205

RAM License

Strontium-82

200 mCi

Rubidium-82

200 mCi

Strontium-85

1000 mCi


No slide title 1264205

Rb-82 Infusion System


No slide title 1264205

Relative Advantages

Rb-82 N-13 ammonia

AvailabilityExcellent Limited

LogisticsEasy Difficult

CostFixed Variable


No slide title 1264205

Decision Analysis

On-site cyclotron

Occasional Imaging

N-13 ammonia

and

PET/CT capacity

Daily Imaging

Rb-82 chloride

and


No slide title 1264205

Decision Analysis

Flexibility

Exercise

Regadenoson

Adenosine

N-13 ammonia

Dipyridamole

Dobutamine

Convenience

Regadenoson

Rb-82 chloride

Adenosine

Dipyridamole


No slide title 1264205

Scheduling

Rb-82 chloride

N-13 ammonia

scheduled > 1D in advance

• problematic cases

inconclusive SPECT

high BMI

scheduled day of exam

• ED and inpatients


No slide title 1264205

Emission protocol

N-13 ammonia

• 20-30 mCi

• 2D gated emission

• start 10 min p injection

Rb-82 chloride

• 40-60 mCi

• 2D gated emission

• start 90 sec p injection


No slide title 1264205

2D vs 3D Gated Rb-82 PET

Knesaurek. BMC Nucl Med 2007;7:4

16 normal volunteers had resting Rb-82 on a BGO PET camera

Low dose (20 mCi) 3D acquisition compared to high dose (60 mCi) 2D acquisition


No slide title 1264205

Emission Reconstruction

Rb-82 chloride

• reconstruction filter: Butterworth 0.4 roll-off / power 10

• post reconstruction: axial smoothing

N-13 ammonia

• reconstruction filter: Butterworth 0.40 roll-off / power 10

• no post reconstruction smoothing


No slide title 1264205

CT protocol

• 140 keV

• 30-210 mAs (noise index 25.0)

• pitch 0.5

• ungated


No slide title 1264205

PET Perfusion Agents

•Rb-82 Chloride and N-13 ammonia are both extractable agents which passively diffuse across cell membranes

•Both tracers have high first-pass myocardial extraction fractions, which are inversely related to flow is a non-linear manner.


No slide title 1264205

Rb-82 chloride

Tang. Phys Med Biol 2009;54:3161-3171

•Rb-82 is rapidly cleared from the circulation


No slide title 1264205

N-13 ammonia

•N13 is rapidly cleared from the circulation


No slide title 1264205

N-13 ammonia

•N-13 ammonia is trapped in the myocardium from the action of glutamate dehydrogenase1 and glutamine synthetase2

NH3

-ketoglutarate

2

1

13NH4+

13NH3

13NH3

glutamine

glutamate

glutamine

urea


No slide title 1264205

PET Perfusion Agents

Relationship to CBF

Rb-82 Chloride

N-13 ammonia

Schelbert Hr, Schwaiger M. In: PET and Autoradiography. Eds: Phelps ME, Mazziotta JC, Schelbert H 1986

Bergman SR. In: PET of the Heart. Eds: Bergmann SR, Sobel BE. 1992


No slide title 1264205

Rb-82

40-60 mCi

60

55

50

45

40

35

30

25

0

20

15

10

5

N-13 ammonia

20-30 mCi

Work Flow

inject

inject

Pers

scan

CT

scan

min

CT

scan

scan

Pers

inject

inject


No slide title 1264205

60

55

50

45

40

35

30

25

0

20

15

10

5

Rb-82 chloride

inject

inject

Pers

scan

CT

scan

min

scan

scan

Aden

CT

inject

inject


No slide title 1264205

60

55

50

45

40

35

30

25

0

20

15

10

5

Rb-82 chloride

inject

inject

Pers

scan

CT

scan

min

scan

scan

Reg

CT

inject

inject


No slide title 1264205

inject

inject

scan

CT

scan

Pers

min

60

55

50

45

40

35

30

25

0

20

15

10

5

inject

inject

25

0

20

15

10

5

CT

scan

Ex

CT

scan

90

85

80

75

70

65

60

•••

min

N-13 ammonia


No slide title 1264205

= inject

60

55

50

45

40

35

30

25

0

20

15

10

5

Injection times

Cyclotron starts production 23 minutes prior to calibration time

Ex

Reg

Ad

Per

Dob


No slide title 1264205

Normal Rb-82 perfusion study


No slide title 1264205

Normal Rb-82 perfusion study


No slide title 1264205

Normal Rb-82 perfusion study


No slide title 1264205

Normal Rb-82 perfusion study


No slide title 1264205

Abnormal Rb-82 perfusion study


No slide title 1264205

Abnormal Rb-82 perfusion study


No slide title 1264205

Normal N-13 perfusion study


No slide title 1264205

Normal N-13 perfusion study


No slide title 1264205

Abnormal N-13 perfusion study

72 year old man with peripheral vascular disease.

Coronary arteriography:

•LAD: 60% ostial and 80% mid vessel stenoses

•LCX: 90% proximal stenosis and occluded OM

•RCA: 90% ostial stenosis


No slide title 1264205

Summary

• PET myocardial perfusion protocols are simple and easy to incorporate in most practices

• Rb-82 and N-13 ammonia are qualitatively equivalent


No slide title 1264205

Summary

• High throughput, and low cost per patient makes Rb-82 PET practical in a high volume practice

• NH3-ammonia PET is better suited for occasional use in patients with inconclusive SPECT, or as the test of choice in problematic patients


  • Login